Skip to main content
. 2020 Apr;8(8):566. doi: 10.21037/atm.2020.02.164

Figure 2.

Figure 2

Summary of the needs of clinicians for the application of iPSCs for the treatment of liver disease. After considering the critical steps for the obtaining of hepatocyte-like cells from pluripotent stem cells, safety issues should be addressed before its translation to the clinics. iPSCs, induced pluripotent stem cells.